On 18q, frequently deleted in late stage colorectal cancers, a gene, Deleted in Colon Cancer (DCC), has been identi®ed and postulated to play a role as a tumor suppressor gene. DCC is retained in the majority of mucinous tumors, which produce high levels of mucins, and seems to be preferentially expressed in intestinal goblet cells. To investigate whether DCC is related to mucin expression and can modulate the transformed phenotype, we introduced a full-length DCC cDNA into HT29 cells, which can be induced in vitro to express MUC2, the gene that encodes the major colonic mucin. Expression of DCC did not modulate constitutive or induced expression of MUC2, nor did DCC induce a mature goblet cell phenotype. However, HT29 clones expressing high and low levels of DCC protein showed a signi®cant decrease in cell proliferation and tumorigenicity. Furthermore, increased shedding and an elevated rate of spontaneous apoptosis were associated with higher levels of expression of DCC. In summary, while restoration of DCC expression in a human colon carcinoma cell line did not in¯uence expression of dierentiation markers, DCC expression did aect the growth and tumorigenic properties of the cells suggesting that DCC can modulate the malignant phenotype of colon cancer.
Introduction
Seventy per cent of colorectal cancers show LOH at chromosome 18q Vogelstein et al., 1988) . On a 18q a gene, Deleted in Colon Cancer (DCC) has been identi®ed and postulated to play a role as a tumor suppressor gene . The DCC gene encodes a transmembrane protein with homology to the neuronal cell adhesion molecule family (N-CAM) , and shares similarity with neogenin, a recently identi®ed gene which is expressed in the developing chicken nervous system (Vielmetter et al., 1994) . In addition, there is evidence that DCC can bind netrin-1, an axonal chemo-attractant involved in the guidance of developing axons (Chen et al., 1996; Keino-Masu et al., 1996; Kolodziej et al., 1996) . In agreement with a postulated role of DCC in the developing nervous system, DCC is expressed at higher levels in the nervous system Hedrick et al., 1994; Reale et al., 1994) , and mice with an inactivated Dcc gene show defects in axonal projections (Fazell et al., 1997) .
Although Dcc null mice do not present obvious alterations in the growth, dierentiation, morphogenesis and tumorigenesis of the intestine, a previous report has suggested an association of DCC with the dierentiation of goblet cells , which in the colon are responsible for synthesizing and secreting mucus (Colony, 1989) . Consistent with a role of DCC in mucin expression, mucinous tumors that are characterized by a large production of mucus, show a lower frequency of LOH at 18q , suggesting that DCC may be required for mucin production.
Our previous work has utilized HT29 cells to study the regulation and structure of a human gastrointestinal mucin gene, MUC2 (Velcich and Augenlicht, 1993; Velcich et al., 1997) , which encodes the major form of intestinal mucins and is expressed predominantly in goblet cells (Chang et al., 1994; Gum et al., 1994; Gendler and Spicer, 1995) . We have shown that in HT29 cells MUC2 gene expression can be induced (Velcich and Augenlicht, 1993) , however, the cells do not acquire a fully dierentiated goblet phenotype, as they fail to polarize and secrete a mucus gel (Velcich et al., 1995) . In addition, we have shown that the MUC2 gene is deregulated in mucinous tumor cell lines (Velcich and Augenlicht, 1993) .
In this report, we investigated potential mechanistic links between DCC expression and the dierentiation pathway of goblet cells: we ascertained whether expression of DCC in HT29 cells could modulate regulation of the MUC2 gene and elaboration of a fully mature goblet cell phenotype. We show that expression of DCC did not modulate the expression of dierentiation markers of the absorptive or goblet cell lineage, but both high and low levels of DCC aected the growth and tumorigenic properties of the cells, and are associated with elevated rates of cell shedding and apoptosis. Therefore, are data, which demonstrate that expression of DCC in a human colon carcinoma cell line alters features of the transformed phenotype, suggest that, in vivo, DCC may act as a modulator of the cancer cell phenotype. This ®nding is consistent with the fact that 18q LOH is linked clinically with colon tumors that progress more rapidly, but 18q LOH is neither necessary nor sucient for progression of the disease.
Results

Phenotypic characteristics of stably transfected HT29 cells expressing the DCC gene
We transfected HT29 cells, which do not express detectable levels of DCC, as determined by RT ± PCR and Western blot analysis (Figure 1a,b) , with an eukaryotic expression vector encoding the full-length human DCC cDNA under control of the cytomegalovirus (CMV) promoter/enhancer elements (CMV ± DCC) (Pierceall et al., 1994) . This vector also contains the neomycin gene that confers resistance to G418. A control vector, harboring only the neo gene (CMVneo), was also used. We were able to establish several clonal cell lines in which DCC expression was detected, and two of these, DCC11 and DCC3, were chosen for our studies, as they expressed low and high levels of DCC mRNA and protein (Figure 1a,b) .
Morphology of the DCC + cells is shown in Figure 2 . Both DCC3 and DCC11 clones showed highly vacuolated monolayers, with this phenotype being more pronounced in the DCC11 cells. Vacuoles were absent from control Neo + cultures, but were present, fewer and smaller, in con¯uent cultures of parental HT29 cells.
DCC expression and goblet cell dierentiation
The normal function of DCC in the intestine has not yet been elucidated, although it has been suggested that DCC may play a role in the dierentiation of the goblet cell lineage . Therefore, we investigated whether expression of DCC was mechanistically linked to the elaboration of the goblet cell phenotype. We have previously shown that HT29 cells can be induced to express a high level of MUC2 mRNA and protein, which represents the major form of colonic mucin, in response to forskolin and TPA (Velcich and Augenlicht, 1993) . Thus, we determined whether the DCC + clones expressed MUC2 mRNA constitutively, or whether DCC could potentiate the responses to treatment with forskolin and TPA. We compared the basal, forskolin and TPA induced levels of MUC2 mRNA in parental (HT29) and control (Neo + ) cells and in the DCC3 and DCC11 clones. As shown in Figure 3 no dierence was detected among the dierent cell groups both in the basal level or induced level of MUC2 expression.
Forskolin and TPA increase MUC2 expression in HT29 cells without inducing a fully dierentiated goblet cell phenotype. In fact, HT29 cells fail to elaborate and secrete fully mature glycosylated mucins (Velcich et al., 1995) . Thus, we investigated whether DCC could overcome this block towards a more dierentiated phenotype. However, parental, control Neo, and DCC3 and DCC11 cultures stained negative with Alcian Blue, a dye commonly used to detect glycosylated acidic mucins (data not shown; Velcich et al., 1995) .
We have previously shown that in HT29 cells dierent inducers can modulate dierent aspects of intestinal cell dierentiation characterized by the induction of markers speci®c for distinct cell lineages (Velcich et al., 1995) . Treatment of HT29 cells with NaB induces aspects of dierentiation along the absorptive cell lineage, as well as apoptosis (Heerdt et al., 1994) . Since the DCC11 clone showed an increased rate of spontaneous apoptosis, we investigated whether expression of DCC could modulate the kinetics and a b Figure 1 Level of expression of DCC in two clones of HT29 cells. (a) Total RNA was isolated from parental HT29 and two independently isolated clones of HT29 cells DCC3 and DCC11 stably transfected with the CMV ± DCC expression vector. 1 mg of RNA was analysed by RT ± PCR reaction for the presence of DCC and GAPDH mRNA, as detailed in Materials and methods. Levels of DCC mRNA are expressed relative to the levels of GAPDH. (b) Western blot analysis of DCC in cytoplasmic cell extracts from the indicated cell lines was performed using the antibody AB-1 in conjunction with the ECL kit as described in Materials and methods. The DCC protein migrates with apparent molecular weight between 170 ± 185 kd. The position and weight (in kilodaltons) of markers are also indicated extent of the response to NaB treatment. Analysis of NaB induction of alkaline phosphatase and CEA, which represent markers for the enterocyte cell lineage, did not reveal any dierence among the dierent cell types (data not shown).
DCC expression aects the growth properties of HT29 cells
Despite the lack of modulation of dierentiation pathways in the DCC + clones, it was clear that DCC aected the growth properties of the cells. To con®rm and expand this observation, we compared the growth kinetics of parental, control Neo + and DCC + clones. As shown in Figure 4 , both DCC2 and DCC11 had slower growth kinetics characterized by a longer lag period after plating, and slower exponential growth rates as compared to parental HT29 and control Neo + cells. A decrease in growth kinetics has been reported in CoKFu cells transformed with the entire human chromosome 18, which harbors DCC (Tanaka et al., 1991) .
As a higher number of cells shed into the supernatant was observed in the DCC11 cultures, we evaluated whether expression of DCC increased rate of shedding of DCC + cells. The fraction of shed cells versus the total number of cells, determined by the DNA concentration in each fraction (Materials and methods) for each cell line as a function of time is shown in Figure 5a . Clearly, DCC11 cultures shed twice as many cells over time than control HT29 cells. DCC3 cells, which express much lower levels of DCC protein than DCC11, had a ratio of¯oating versus adherent cells which was similar to controls.
This altered shedding activity is suggestive of cells undergoing apoptosis (Heerdt et al., 1994) ; in addition, a recent report establishes that transient expression of DCC in 293T embryonic kidney cells induces high levels of apoptosis (Mehelen et al., 1998) . Thus, we investigated whether the expression of DCC caused an increase in the rate of apoptosis in the monolayer of , DCC3 and DCC11 cells were not treated or treated with forskolin (F) or TPA for 8 h, as previously reported (Velcich and Augenlicht, 1993) . Total RNA was isolated and levels of MUC2 mRNA were determined by Northern blot analysis. Also shown are the levels of GAPDH mRNA for comparative purposes. The polydispersity of the MUC2 RNA is a characteristic of many mucin mRNAs (Velcich et al., 1997) (Figure 5c ). The excellent correlation we found between the¯ow cytometric analysis and the colorimetric method for measuring apoptotic cells con®rms previous reports (Nicoletti et al., 1991; Heerdt et al., 1996) .
DCC expression suppresses tumorigenicity both in vitro and in vivo
The DCC gene was originally isolated as a candidate tumor suppressor gene involved in the development of colon cancer. In view of the decreased growth characteristics of the DCC + clones and increased rate of apoptosis, whose inhibition has been reported during development of colorectal cancer (Bedi et al., 1995) , we investigated the properties of DCC as a tumor suppressor gene, and determined whether the expression of wild type DCC gene altered the transformed phenotype of HT29 cells. First, we evaluated the ability of control HT29, Neo + and DCC + cells to form colonies in soft agar. The inability of cells to grow in soft agar is generally an indication of a more normal phenotype. Figure 6a shows that both stably transformed clones, DCC3 and DCC11, failed to generate colonies when plated in soft agar. Conversely, both parental and control Neo + cells were capable of forming large size colonies under the same conditions. The results shown in Figure 6a were highly reproducible in three independent experiments, each performed in six replicas. To con®rm and expand these results, we tested the ability of the cells in each group (HT29, Neo + , DCC3 and DCC11), to grow as xenografts in immunode®cient mice. Nude mice were injected subcutaneously, as detailed in Materials and methods. The kinetics of tumor growth, as determined in bi-weekly measurements, is shown in Figure 6b . 
Discussion
It has been suggested that DCC may play a role in the dierentiation of the goblet cell lineage . In the colon, goblet cells are responsible for synthesizing and secreting mucus. Consistent with a role of DCC in mucin expression, mucinous tumors, that are characterized by a large production of mucus, show a lower frequency of LOH at 18q than do common colonic tumors , suggesting that DCC may be required for mucin production. In an extension of our previous work showing that HT29 cells can be induced to express high levels of MUC2 mRNA and protein, but fail to acquire a fully dierentiated phenotype (Velcich et al., 1995) , we investigated whether expression of DCC was mechanistically linked to the elaboration of the goblet cell phenotype. Our data show that DCC does not modulate the expression of MUC2 constitutively or MUC2 induced by TPA and forskolin, nor does DCC confer to HT29 cells the ability to elaborate a mature goblet cell phenotype in response to agents which induce expression of MUC2. In sum, our data argue that, at least in this in vitro system, DCC is not required for mucin production. In addition, DCC did not alter the induction of CEA or alkaline phosphatase by sodium butyrate. DCC + clones have slower growth kinetics and, accordingly, the DCC + clones show a decreased ability to form colonies in soft agar, and decreased tumorigenesis in nude mice. Thus, our results in colonic cells correlate restoration of DCC expression, at both low or higher level, with the suppression of aspects of the transformed phenotype and are in agreement with previous work demonstrating that the reintroduction of the entire chromosome 18 in a DCC 7 colorectal cancer cell line, or expression of the DCC cDNA in DCC 7 transformed keratinocytes, suppress cell tumorigenicity (Tanaka et al., 1991; Klingelhutz et al., 1995) . Furthermore, restoration of DCC expression increased shedding and rate of spontaneous apoptosis in DCC11 cells, which express the higher levels of DCC protein. These data are in agreement with a recent work demonstrating that transient expression of DCC in 293 cells induces apoptosis (Meheleh et al., 1998) . The discrepancy between high levels of apoptosis in 293 embryonic kidney cells and the more modest, but statistically signi®cant, increase we detect in HT29 cells, may be due to the dierent cell systems or the assay of transient transfectants in the 293 cells versus stable transformants in our work, since the selection of such stable transformants would, of necessity, select against cells which can eciently progress to the end stage of apoptosis.
Increased apoptosis may represent an aspect of the attenuated tumorigenic phenotype associated with restoration of DCC expression. Interestingly, this modulation is not observed in the DCC3 clone which expresses a very low level of DCC protein, despite the fact that DCC3 cells display an attenuated tumorigenic phenotype, both in vitro and in vivo, comparable to that of DCC11 cells. There are several possible explanations for these observations: either these two processes, increased shedding and rate of apoptosis, and decreased tumorigenicity, may be controlled by distinct mechanisms that can be dierentially modulated by levels of DCC expression; or small alterations in the rate of apoptosis may be induced by low levels of DCC and, although dicult to detect because of the transient nature of the process, may still be highly signi®cant in altering tumor growth (Bursch et al., 1990) . In addition, our results are consistent with in vivo data showing that only a small percentage of colonic cells in situ can be identi®ed at the terminal stage of apoptosis.
An attenuated transformed phenotype is also inferred by the cell morphology: DCC clones are characterized by the presence of large vacuoles, which may be similar to the intracellular lumina, a distinct feature of cells unable to develop cell polarity (Laboisse, 1989) . Interestingly, similar structures have 3 cells per well were seeded in soft agar (0.5% bottom layer and 0.33% top layer) and cultured for 2 weeks. Colonies were visualized by staining with a vital tetrazolium dye, as described in Materials and methods, and photographed. Three independent experiments were performed, each in six replicas, and representative wells for each cell line are shown. (b) To determine tumor growth kinetics of DCC + clones 10 6 cells, per cell line, were injected subcutaneously in nu/nu females. At the indicated time points after injection two dimensional measurements were taken and volume was calculated with the following formula ((L6W)63.14)/6. Linear regression analysis shows that the mean square root of tumor volume between DCC + cells and controls (HT29 and Neo + ) were signi®cantly dierent (P50.01) been described during epithelia morphogenesis in fetal rat colon (Colony and Neutra, 1983) .
The growth suppressive eects, increased rate of apoptosis and the presence of vacuoles could be due to a toxic eect of the DCC protein expressed at elevated levels from a constitutive promoter. However, the fact that we were able to establish several independent clones which have dierent levels of DCC, yet show a similar, less tumorigenic, phenotype, and the presence of similar, though less prominent, vacuoles in parental cultures, argue against this possibility.
Our results demonstrating that DCC can modulate the tumorigenicity of a colonic carcinoma cell line, are consistent with the role attributed to DCC in colorectal carcinogenesis. DCC was originally cloned as the candidate target gene of 18q LOH. This cytogenetic abnormality is detected in the majority of primary colon carcinomas and almost 100% in liver metastasis, suggesting that 18q LOH is associated with tumor progression (Vogelstein et al., 1988; Ookawa et al., 1993) . Although somatic mutations in the remaining DCC allele have been detected in few cases , there is marked reduction or absence of DCC expression in colorectal cancer (Cho and Fearon, 1995; Itoh et al., 1993) , and recent reports correlate the loss of DCC expression with poor prognosis (Jen et al., 1994; Shibata et al., 1996) . In addition, a role for DCC in tumor progression has been substantiated by numerous reports describing alterations in DCC in tumors derived from dierent organs (Fearon, 1996; Rieger-Christ et al., 1997) , including the brain, where DCC is expressed at its highest levels, and, as in the case for colorectal cancer, 18q LOH is associated with a propensity of tumor cells to metastasize Reyes Mugica et al., 1997 .
Additional candidate genes at 18q12-21, include DPC4 and MADR2/JV18 Eppert et al., 1996; Riggins et al., 1996) , now renamed Smad4 and Smad2 (Derynk et al., 1996) . These two loci show inactivating mutations in 16 and 6% of colon cancers, respectively. Further evidence for the role of these genes in colorectal cancer comes from a recent report that inactivation of the murine Smad4 gene accelerates tumor formation in the genetically initiated Apc +/7 mice (Takaku et al., 1998) . However, a careful analysis of a panel of colorectal tumor xenografts determined that, although DPC4 and JV18 showed inactivation in a subset of colon tumors, the frequency of alteration in the panel was not suciently high to make these genes the sole candidate targets for inactivation (Eppert et al., 1996; Thiagalingam et al., 1996) . Conversely, all the tumors studied in detail showed aberrant expression of DCC , and absence of DCC expression was correlated with poor prognosis (Shibata et al., 1996) .
The controversy on the role of 18q21 LOH in general (Carethers et al., 1998; Martinez-Lopez et al., 1998) and loss of DCC expression in particular (Shibata et al., 1996; Gotley et al., 1996) in colon tumorigenesis has been further fueled by the ®nding that targeted inactivation of the mouse Dcc gene does not play a detectable role in the process of tumor formation in the gastrointestinal tract (Fazell et al., 1997) , even in the genetically initiated Min mouse which harbors a mutated Apc allele (Moser et al., 1990) . However, there are two important aspects of these ®ndings that need to be kept in proper context: the extent to which ®ndings in the mouse can be extrapolated to human disease; and the phenotype one would expect to observe based on the clinical observations regarding 18q LOH. First, the sequence of events that cause tumor formation in the mouse may be dierent from human. In this regard, tumors which develop in the Apc +/7 animal models do not accumulate ras and p53 mutations (Shoemaker et al., 1997; Smits et al., 1997) , and the min phenotype is not potentiated in mice which also have targeted expression of kras and p53 mutant transgenes in the intestine (Kim et al., 1993) . In contrast, in human, ras and p53 mutations play a role in tumor progression, being present in approximately 50 and 75% of colorectal carcinoma .
The discrepancy between the mouse and human data for several loci may in part be attributed to the fact that DCC (as well as p53) inactivation is a late event in the progression of human colon cancer, generally associated with the increased propensity of tumor cells to metastasize, while in mice tumors of the gastrointestinal tract vary rarely metastasize. Thus, late events in tumor progression in human, which are dependent upon a great complexity of changes in gene structure and expression (Augenlicht et al., 1991; Zhang et al., 1997) , seem to be dicult to reproduce in mouse. In this regard it will be interesting to evaluate whether the absence of Dcc in the Smad3 7/7 mice which develop metastatic colonic tumors (Zhu et al., 1998) , would facilitate the appearance of metastasis. Second, multiple target loci are present in 18q which may have a role in progression by modulating the tumor phenotype; however, since 18q LOH is not sucient nor necessary for human colon tumorigenesis, expectation that individual target genes on the chromosome could initiate or suppress tumorigenesis, may be simplistic. Instead, our ®nding that DCC expression can modulate the transformed phenotype of colonic carcinoma cells is entirely consistent with the clinical observation that 18q LOH status is linked to prognosis, but that even those patients who retain 18q still exhibit progressive, although less aggressive, disease.
Materials and methods
Cell culture and transfection protocol HT29 cells were maintained in minimal essential medium supplemented with non-essential amino acids and 10% fetal calf serum. For transfection, 1610 6 cells were seeded in 100 mm dishes 2 days prior to transfection. Cells were transfected using 50 mg of the plasmid CMV ± DCC (a generous gift of B Vogelstein), and 50 ml of lipofectAMINE (Gibco/BRL) following the manufacturer's instructions. Incubation of cells with the liposome ± DNA complex was for 5 h followed by the addition of fresh medium. Forty-eight hours later, cells were split into 66100 mm dishes in complete medium containing 800 mg/ml of G418. Individual colonies were isolated, expanded and further characterized. Induction of cells with TPA and forskolin was for 8 h as previously described (Velcich and Augenlicht, 1993) .
RNA isolation and analysis, and immunoblots
RNA was isolated, from DCC + and control cells, as previously described (Velcich and Augenlicht, 1993) , and analysed by RT ± PCR. For ®rst strand cDNA synthesis 1 mg of total RNA was used in 20 ml of RT reaction using an RNA ± PCR kit (Perkin Elmer) according to the manufacturer's instructions. Ten ml of the RT reactions were ampli®ed using the DCC primers described by . The other 5 ml were ampli®ed using primers speci®c for GAPDH. These conditions were chosen after pilot experiments were carried out to establish that reactions were performed in the linear range.
PCR products were analysed by electrophoresis on agarose gel, followed by blotting and hybridization to DCC and GAPDH speci®c probes. The intensity of the bands was determined using a Phosphoimager (Molecular Dynamics). MUC2 expression was determined as previously described by Northern blot analysis (Velcich and Augenlicht, 1993) .
For Western blot analysis, total cell extracts from the cell lines were prepared as previously described (Velcich et al., 1995) . Equal amounts of protein, as determined by the Bradford microassay (BioRad), were diluted with an equal volume of 26 sample buer, boiled for 5' and fractionated by electrophoresis on a 8% precasted polyacrylamide gel, followed by electrotransfer to nitrocellulose. After transfer, ®lters were stained with Ponceau S to control for equal loading and transfer. The DCC speci®c band was detected by using monoclonal antibody DCC Ab-1 (Oncogene Research Products) following the supplier's instructions. Immune complexes were visualized using the ECL kit (Amersham) following the manufacturer's instructions. Positive control for the DCC protein was represented by cell extract from the IMR32 cells, a human neuroblastoma cell line which expresses wild type DCC (Pierceall et al., 1994) .
Cell proliferation, cell growth in soft agar, and tumor xenograft Kinetics of cell growth were determined by seeding 10 3 cells per well in 96 well plates for each cell group. At the indicated time points cells, in triplicate, were trypsinized and counted using a Coulter counter.
For the soft agar colony assay, one 6 well plate was used per cell type. 5610 6 cells in 1 ml of top agar (0.33%) in complete medium were seeded on a layer of 3 ml of bottom agar (0.5%). After 1 week cells were fed with 1 ml of complete medium, with care taken not to disturb the top layer. Colonies were visualized 2 weeks after plating by staining with vital tetrazolium dye (Schaeer and Friend, 1976) and photographed. In vivo tumorigenicity was evaluated by injecting subcutaneously 10 6 cells in nude/nude BalbC female, 4 ± 6-week-old, mice. Tumor growth was recorded twice weekly.
Cellular shedding, DNA fragmentation and¯ow cytometric analysis DNA fragmentation was determined as the fraction of low molecular weight DNA from the monolayer of cell cultures (Heerdt et al., 1996) . Brie¯y, cells were seeded at 5610 4 per well in 24 well plates. Three days later fresh medium was added and, at the indicated time points, cells in the supernatant and monolayer were harvested, washed twice in phosphate buered saline solution (PBS), resuspended in 100 ml of lysis buer (10 mM Tris pH 7.2, 1 mM EDTA, 0.2% Triton X-100) and kept on ice for 10 min. The high molecular weight DNA fraction was pelleted and the supernatant, containing the low molecular weight DNA, transferred to a clean tube. The high molecular weight DNA fraction was resuspended in 100 ml of lysis buer. DNA from the three dierent fractions (shed, low and high molecular weight DNA from monolayer) was precipitated with 12.5% (®nal concentration) trichloroacetic acid (TCA) overnight at 48C. DNA pellets were extracted in 80 ml of 5% TCA by heating at 908C for 10 min. Perchloric acid was added to a ®nal concentration of 0.5 N. DNA concentration was determined by the diphenylamine method (DPA). 200 ml of freshly prepared reagent (150 mg DPA, 150 ml of H 2 SO 4 , and 50 ml of acetaldehyde (16 mg/ml)/10 ml of glacial acetic acid) were added to the DNA samples. The color reaction was developed at 308C overnight and samples were read at 590 nm along with a standard curve prepared from salmon sperm DNA. The fraction of DNA from cells in the supernatant, expressed as percentage of total DNA, is an index of cell shedding.
The¯ow cytometric analysis of propidium iodide stained nuclei was performed as described by Nicoletti et al. (1991) . The¯uorescence of individual nuclei was measured and the recorded data analysed using a FACScan¯ow cytometer and software (Becton Dickinson) respectively.
